New Steroid Law Now Criminalizes List of 25 Steroids. Bringing More Severe Criminal and Civil Penalties Surrounding Possession. Along with Distribution of Anabolic Steroids as well as “Most” Prohormone Supplements.

The Designer Anabolic Steroid Control Act of 2014 (H.R. 4771). A bill that would expand the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA). Including about two dozen new substances. Establishing new crimes relating to false labeling of steroids.^[1] This type of steroid enhances muscles. The bill would establish a penalty of up to $500,000. Found to be falsely labeling their anabolic steroid products.

The bill, introduced into the United States House of Representatives during the 113th United States Congress.

Anabolic Steroids

Anabolic steroids, technically known as anabolic-androgenic steroids (AAS).  Drugs structurally related to the cyclic steroid ring system.  With similar effects to testosterone in the body. They increase protein within cells, especially in skeletal muscles.

Anabolic steroids were first made in the 1930s.  Now used therapeutically in medicine to stimulate muscle growth and appetite. While inducing male puberty and treat chronic wasting conditions, such as cancer and AIDS. The American College of Sports Medicine acknowledges that AAS, in the presence of adequate diet. Contributes to increases in body weight, often as lean mass increases. While gains in muscular strength achieved through high-intensity exercise and proper diet.  Increasing the use of AAS in some individuals.

Health risks produced by long-term use or excessive doses of anabolic steroids. These effects include harmful changes in cholesterol levels (increased low-density lipoprotein and decreased high-density lipoprotein), acne, high blood pressure, liver damage (mainly with oral steroids), and dangerous changes in the structure of the left ventricle of the heart. Conditions pertaining to hormonal imbalances such as gynecomastia and testicular atrophy also caused by anabolic steroids.

Ergogenic uses for anabolic steroids in sports, racing, and bodybuilding as performance-enhancing drugs are controversial because of their adverse effects and the potential to gain unfair advantage is considered cheating. Their use is referred to as doping and banned by all major sporting bodies. For many years, AAS have been by far the most detected doping substances in IOC-accredited laboratories. In countries where AAS are controlled substances, there is often a black market in which smuggled, clandestinely manufactured or even counterfeit drugs are sold to users.

One estimate indicates that over 10 million Americans a year take anabolic steroids approximately four percent of whom are adolescents.

Provisions of the bill

The Designer Anabolic Steroid Control Act of 2014 would amend the Controlled Substances Act to: (1) expand the list of substances defined as “anabolic steroids”; (2) authorize the United States Attorney General to issue a temporary order adding a drug or other substance to the list of anabolic steroids; (3) impose enhanced criminal and civil penalties for possessing or trafficking in any anabolic steroid, or product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclatureused by the International Union of Pure and Applied Chemistry; and (4) authorize the Attorney General to collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled.

The bill would specify that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anaboloic steroid if it is: (1) an herb or other botanical; (2) a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical; (3) a combination of two or more such substances (i.e., botanical or concentrate, metabolite, or extract); or (4) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act. Provides that any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden of providing the appropriate evidence.

Congressional Budget Office report

This summary , based largely on the summary provided by the Congressional Budget Office, as ordered reported by the House Committee on Energy and Commerce on July 15, 2014. This is a public domain source.

The Congressional Budget Office (CBO) estimates that implementing H.R. 4771 would have no significant costs to the federal government. Enacting the bill could affect direct spending and revenues; therefore, pay-as-you-go procedures apply. However, CBO estimates that any effects would be insignificant for each year.

Offenders and cost

H.R. 4771 would expand the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and would establish new crimes relating to false labeling of steroids. As a result, the government might be able to pursue cases involving drug use that it otherwise would not be able to prosecute. CBO expects that H.R. 4771 would apply to a relatively small number of additional offenders, however, so any increase in costs for law enforcement, court proceedings, or prison operations would not be significant. Any such costs would be subject to the availability of appropriated funds.

Because those prosecuted and convicted under H.R. 4771, subject to civil and criminal fines, the federal government might collect additional fines if the legislation enacted. Civil fines recorded as revenues. Criminal fines recorded as revenues, deposited in the Crime Victims Fund, and later spent. CBO expects that any additional revenues and direct spending not significant because of the small number of additional cases likely to be affected.

H.R. 4771 contains no intergovernmental mandates as defined in the Unfunded Mandates Reform Act (UMRA) and would impose no costs on state, local, or tribal governments.

H.R. 4771 Imposes

H.R. 4771 would impose private-sector mandates, as defined in UMRA, on manufacturers, sellers, importers, exporters, distributors, and consumers of products that contain certain chemical compounds defined as anabolic steroids. CBO estimates that the cost of complying with those mandates would probably exceed the annual threshold established in UMRA for private-sector mandates ($152 million in 2014, adjusted annually for inflation).

The bill would impose private-sector mandates by adding 25 new compounds. Any compounds found to be structurally similar. The list of anabolic steroids regulated under the Controlled Substances Act. Consumers would need a prescription from a licensed practitioner in order to purchase products containing the newly listed compounds. Sellers, manufacturers, and importers of such products required to obtain an authorization from state and federal authorities. While making  or possess the compounds.

Regulations

However, based on information from the Food and Drug Administration (FDA), the DEA, and industry professionals, CBO expects that the majority of the affected entities would either replace the regulated compounds with new ones or discontinue the distribution of the affected products. Therefore, the cost of the mandate forgoes income from lost sales.

Because the nature marketing regulated. Scope of sales affected is difficult to determine. As products are found to contain compounds structurally similar to the compounds listed. Industry sales could decline significantly. Some industry experts estimate that the revenues generated from sales of products containing such compounds amount to between $2 billion and $5 billion annually. (Those figures include sales of some products that already not in compliance or not sold in compliance with FDA or DEA regulations.)

Although identifying which affected by the legislation,difficult at most.  Given the estimated magnitude of industry profits, even a 10 percent decrease in income as a result of the  bill exceeds the annual threshold for private-sector mandates.

The bill also imposes a mandate on importers, exporters, manufacturers, and distributors. Requiring that any anabolic steroid or product containing an anabolic steroid labeled as such. Using the nomenclature of the International Union of Pure and Applied Chemistry. While the cost of the mandate – small.

Procedural history

The Designer Anabolic Steroid Control Act of 2014, introduced into the United States House of Representatives on May 29, 2014 by Rep. Joseph R. Pitts (R, PA-16). The bill was referred to the United States House Committee on Energy and Commerce, the United States House Committee on the Judiciary, the United States House Energy Subcommittee on Health, and the United States House Judiciary Subcommittee on Crime, Terrorism, Homeland Security and Investigations. On September 15, 2014, the House voted to pass the bill in a voice vote.

Debate and discussion

Rep. Pitts, who sponsored the bill. Added the bill “will protect consumers from these harmful products by giving the DEA the tools and authority to classify designer steroids as controlled substances.”

Delegate Donna Christensen (D-VI) was also in favor of the bill. Arguing that it “will go a long way to removing dangerous steroids from the market.”

Supporters argued that the bill would “make it easier for the attorney general to identify legally sold commercial products that contain illicit anabolic steroids.” The United Natural Products Alliance and the Council for Responsible Nutrition both supported the bill.

Fines and Felonies

After Congress passed law last week, the Designer Anabolic Steroid Control Act or “DASCA”.  While signed into law by President Obama on Thursday, December 18^th.    Resulting in major legal changes surrounding the criminal possession and distribution of androgenic steroids. DASCA criminalized 25 new anabolic steroids literally overnight. The law effective immediately – No grace period. The new law on designer steroids also targets the derivatives, prohormones and slight variations on compounds. On the new list of substances (if made or marketed/intended marketing to build muscle).  

Changes the way steroid cases prosecuted moving forward. DASCA brings increased criminal and civil penalties. Also,massive fines. While a major impact surrounding all aspects of steroids and the law. In summary this new law makes selling, possessing, transporting, controlling, or even conspiring to any of the aforementioned, a felony. Furthermore, this law has put many large distribution companies out of business literally overnight !

So Is There Good News In Any Of This ?

YES – LEGAL PROHORMONE SUPPLEMENTS, LEGAL STEROIDS, AND ANABOLIC SUPPLEMENTS, NOT BANNED AND STILL LEGAL FOR PURCHASE AND USE !